Total Payments
$6,971
2024 Payments
$1,051
Companies
36
Transactions
234
Medicare Patients
832
Medicare Billing
$60,125
Payment Breakdown by Category
Food & Beverage$6,971 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,971 | 234 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,425 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $869.32 | 33 | $0 (2024) |
| Lilly USA, LLC | $826.24 | 37 | $0 (2024) |
| Novo Nordisk Inc | $537.75 | 24 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $406.87 | 11 | $0 (2024) |
| Amgen Inc. | $297.19 | 5 | $0 (2024) |
| ABBVIE INC. | $210.91 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $177.68 | 8 | $0 (2022) |
| IDORSIA PHARMACEUTICALS US INC | $165.73 | 3 | $0 (2023) |
| Astellas Pharma US Inc | $134.06 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,051 | 25 | Amgen Inc. ($282.52) |
| 2023 | $2,166 | 51 | AstraZeneca Pharmaceuticals LP ($849.07) |
| 2022 | $2,212 | 88 | Lilly USA, LLC ($423.90) |
| 2021 | $1,542 | 70 | GlaxoSmithKline, LLC. ($317.48) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Obesity | ||||||
| 10/15/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $122.88 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.53 | General |
| Category: Cardiovascular | ||||||
| 06/17/2024 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Inflammation | ||||||
| 05/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $123.46 | General |
| Category: Cardiology | ||||||
| 05/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Endocrinology | ||||||
| 04/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $32.42 | General |
| Category: Oncology | ||||||
| 04/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Cardio-renal | ||||||
| 04/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Inflammation | ||||||
| 02/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.62 | General |
| 02/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $122.88 | General |
| Category: Cardiology | ||||||
| 02/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.39 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Cardio-renal | ||||||
| 01/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: Obesity | ||||||
| 01/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Neuropsychiatry | ||||||
| 01/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 196 | 231 | $32,490 | $13,261 |
| 2022 | 8 | 232 | 276 | $32,840 | $15,812 |
| 2021 | 8 | 249 | 309 | $39,560 | $18,372 |
| 2020 | 5 | 155 | 196 | $29,249 | $12,679 |
Total Patients
832
Total Services
1,012
Medicare Billing
$60,125
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 76 | $14,000 | $5,012 | 35.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $8,100 | $4,729 | 58.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 31 | $5,195 | $1,666 | 32.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 29 | $2,320 | $816.63 | 35.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 37 | 37 | $925.00 | $553.52 | 59.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 13 | 13 | $1,950 | $484.38 | 24.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 53 | 53 | $9,540 | $5,728 | 60.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 79 | $13,430 | $5,487 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 21 | $2,680 | $1,018 | 38.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 33 | $2,640 | $999.00 | 37.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 14 | 14 | $1,060 | $973.60 | 91.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 42 | 42 | $1,050 | $636.21 | 60.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 15 | 18 | $1,800 | $515.18 | 28.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $640.00 | $456.00 | 71.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 60 | 60 | $10,800 | $6,723 | 62.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 92 | $15,670 | $5,765 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 56 | $7,055 | $2,586 | 36.7% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 20 | 20 | $1,400 | $1,329 | 94.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 14 | 21 | $2,100 | $694.25 | 33.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 14 | $1,040 | $532.70 | 51.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $920.00 | $379.96 | 41.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 23 | 23 | $575.00 | $361.79 | 62.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 92 | $15,620 | $6,044 | 38.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 45 | 45 | $8,100 | $4,405 | 54.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 30 | $3,979 | $1,177 | 29.6% |
About Marsha Smith
Marsha Smith is a Family healthcare provider based in Troy, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346324100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marsha Smith has received a total of $6,971 in payments from pharmaceutical and medical device companies, with $1,051 received in 2024. These payments were reported across 234 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,971).
As a Medicare-enrolled provider, Smith has provided services to 832 Medicare beneficiaries, totaling 1,012 services with total Medicare billing of $60,125. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Troy, NY
- Active Since 10/25/2006
- Last Updated 03/01/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1346324100
Products in Payments
- FARXIGA (Drug) $826.00
- TRELEGY ELLIPTA (Drug) $572.43
- BREZTRI (Drug) $477.99
- Kerendia (Drug) $406.87
- TRULICITY (Drug) $393.13
- MOUNJARO (Drug) $379.87
- Repatha (Biological) $246.34
- Ozempic (Drug) $223.89
- XARELTO (Drug) $177.68
- QUVIVIQ (Drug) $165.73
- NURTEC ODT (Drug) $128.35
- DUPIXENT (Biological) $123.93
- KRYSTEXXA (Biological) $122.88
- Qelbree (Drug) $122.88
- KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) $121.67
- AIRSUPRA (Drug) $121.39
- RYBELSUS (Drug) $120.98
- AFREZZA (Drug) $114.44
- Cologuard Collection Kit (Device) $109.99
- INGREZZA (Drug) $102.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Troy
Mrs. Daniela Maxim, Fnp-Bc, FNP-BC
Family — Payments: $97,995
Family $97,995
Stephanie Reese
Family — Payments: $15,477
Family $15,477
Deidra Knauth, Fnp, FNP
Family — Payments: $13,328
Family $13,328
Mrs. Pamela Jones, R.n., N.p, R.N., N.P
Family — Payments: $11,382
Family $11,382
Mackenzie Difiore, Np, NP
Family — Payments: $9,161
Family $9,161
Ms. Meaghan Hogan, Fnp, FNP
Family — Payments: $6,421
Family $6,421